S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
Log in
ASX:EMD

Emyria Limited (EMD.AX) Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
A$0.06
MA: A$0.06
A$0.06
52-Week Range N/A
Volume471,333 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Emyria Limited, a healthcare technology and services company, operates a network of specialist medical clinics. Its medical clinics offer treatments, such as cannabinoid-based medicines. As of July 31, 2020, the company operated four patient-focused medical clinics. It has a partnership agreement with Mind Medicine Australia to co-develop a gold-standard and data-driven clinical model for the safe provision of psychedelic-assisted therapies in Australia. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is based in West Leederville, Australia.

MarketRank

Overall MarketRank

0.60 out of 5 stars

Analyst Opinion: 0.0Community Rank: 3.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Health Information Services
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 8 6559 2800
EmployeesN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$1.01 million
Book ValueA$0.02 per share

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Receive EMD News and Ratings via Email

Sign-up to receive the latest news and ratings for EMD and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Emyria Limited (EMD.AX) (ASX:EMD) Frequently Asked Questions

What stocks does MarketBeat like better than Emyria Limited (EMD.AX)?

Wall Street analysts have given Emyria Limited (EMD.AX) a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Emyria Limited (EMD.AX) wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are some of Emyria Limited (EMD.AX)'s key competitors?

Who are Emyria Limited (EMD.AX)'s key executives?

Emyria Limited (EMD.AX)'s management team includes the following people:
  • Dr. Stewart James Washer B.Sc., BSc (Hons), Ph.D., Exec. Chairman (Age 50, Pay $259.94k)
  • Dr. Michael Winlo, MD & Director
  • Ms. Su-Mei Sain, Chief Financial Officer
  • Mr. Adam James, Chief Operating Officer
  • Dr. Alistair Vickery, Exec. Medical Director & Director
  • Mr. Simon Robertson C.A., B.Bus, M Appl. Fin, CA, Company Sec.

What is Emyria Limited (EMD.AX)'s stock symbol?

Emyria Limited (EMD.AX) trades on the ASX under the ticker symbol "EMD."

How big of a company is Emyria Limited (EMD.AX)?

Emyria Limited (EMD.AX) has a market capitalization of $0.00 and generates $1.01 million in revenue each year.

What is Emyria Limited (EMD.AX)'s official website?

The official website for Emyria Limited (EMD.AX) is www.emeraldclinics.com.au.

How can I contact Emyria Limited (EMD.AX)?

The company can be reached via phone at 61 8 6559 2800.

This page was last updated on 1/18/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.